NEWCaplight raises a $16M Series A, led by BlackRock and Fin Capital →
Skip to main content
Caplight Logo









CytoSite Bio

CytoSite Bio

Private
Boston, MassachusettsHealthcare & Life Scienceshttps://cytositebio.com/

Last Round

Seed

Sep 24, 2020

Total Funding Raised

$7.87M

Company Overview

CytoSite Bio is a biotechnology company that develops Granzyme B-targeted radiopharmaceuticals and PET imaging agents to assess and improve immunotherapy efficacy in cancer and autoimmune disease patients.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Medical Imaging, Precision Medicine, Clinical Trials

Business Model

B2B

Customer Profile

Revenue Share, Services & Consulting

AI Layer

Non-AI

Keywords

radiopharmaceuticalsPET imagingimmuno-oncologyprecision medicinemolecular imagingradiotracerimmune activationclinical trial supportbiomarkertheranosticscancer imagingdrug developmentPositron Emission TomographyPET

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

CytoSite Bio Comparables

Compare CytoSite Bio with similar companies based on industry and business-model similarity.

CytoSite Bio comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
CellSight Technologies
87%
Telix Pharmaceuticals
79%
GE HealthCare Technologies Inc.
78%

CytoSite Bio Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
SeedSep 24, 2020
Series AAug 9, 2018

Key People

Founding team and executive leadership

Benjamin Larimer

Chief Executive Officer

Executive Team

CytoSite Bio Investors

Notable investors and investment history

CytoSite Bio investors
InvestorRounds
National Cancer InstituteSeed
NIH RADxGrant
Acorn Campus TaiwanSeed
First Avenue VenturesSeries A

Market signals

Structured signals derived from secondary market and firmographic data.

  • Mar 2, 2026

    Monthly visitors grew 85% MoM.

CytoSite Bio Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

CytoSite Bio Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about CytoSite Bio's valuation, stock price, and market status.

Firmographic Details

HeadquartersBoston, Massachusetts
Employee Range6
Year Founded2016
Last FundingSep 24, 2020

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.